Pharmacogenomics, better known as gene-based therapy, represents a revolutionary new way to look at treatments across all populations. Increasingly, genomics courses are being taught in pharmacy schools as the profession shifts more towards individual-based medicine. But how has academia caught up with this sweeping clinical trend?

According to polls taken annually at St. John’s University, the percentage of PharmD candidates expressing an interest in pharmacogenomics has steadily increased over the past five years. Amongst faculty, the interest has risen to the point where professors and students are working together to run clinical pharmacogenomics projects. (Poll shown in Figure 1 taken from anonymous St. John’s University College of Pharmacy and Health Sciences students from 2010 to 2015).